Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-18-003152
Filing Date
2018-03-19
Accepted
2018-03-19 16:48:54
Documents
54
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO QUARTERLY REPORT f10q0617a1_americanbrivision.htm 10-Q/A 592057
2 CERTIFICATION f10q0617a1ex31-1_americanb.htm EX-31.1 9345
3 CERTIFICATION f10q0617a1ex31-2_americanb.htm EX-31.2 9488
4 CERTIFICATION f10q0617a1ex32-1_americanb.htm EX-32.1 3835
5 CERTIFICATION f10q0617a1ex32-2_americanb.htm EX-32.2 3740
  Complete submission text file 0001213900-18-003152.txt   3566249

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtoo-20170630.xml EX-101.INS 712783
7 XBRL SCHEMA FILE mtoo-20170630.xsd EX-101.SCH 34117
8 XBRL CALCULATION FILE mtoo-20170630_cal.xml EX-101.CAL 28610
9 XBRL DEFINITION FILE mtoo-20170630_def.xml EX-101.DEF 108845
10 XBRL LABEL FILE mtoo-20170630_lab.xml EX-101.LAB 227458
11 XBRL PRESENTATION FILE mtoo-20170630_pre.xml EX-101.PRE 203040
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 333-91436 | Film No.: 18699375
SIC: 2834 Pharmaceutical Preparations